Cargando…
COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024142/ https://www.ncbi.nlm.nih.gov/pubmed/33814381 |
Ejemplares similares
-
COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine
Publicado: (2021) -
Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine
Publicado: (2021) -
COVAX calls for urgent action to close vaccine equity gap
Publicado: (2022) -
Joint COVAX statement on the equal recognition of vaccines
Publicado: (2021) -
WHO working closely with countries responding to monkeypox
Publicado: (2022)